A grant of up to $38.9 million has been awarded to Children's Hospital of Philadelphia (CHOP) for a five-year research project aiming to create personalized gene-editing therapies for four rare genetic disorders related to the liver. The focus will be on developing treatments customized for each specific disorder. This project reflects a significant investment in advancing medical treatment options for patients with these conditions.